Kłos Marta, Jachowicz Estera, Pomorska-Wesołowska Monika, Romaniszyn Dorota, Kandzierski Grzegorz, Wójkowska-Mach Jadwiga
Department of Molecular Biology, Faculty of Science and Health, Catholic University of Lublin, 20-708 Lublin, Poland.
Department of Microbiology, Faculty of Medicine, Medical College, Jagiellonian University, 31-121 Kraków, Poland.
J Clin Med. 2022 Jul 6;11(14):3927. doi: 10.3390/jcm11143927.
The aim of this study was to highlight antimicrobial resistance among isolated from bloodstream infections in hospitals in southern Poland. The present study includes laboratory-confirmed secondary bloodstream infections (LC-BSIs), in the years 2015-2018, in hospitalized adult patients (≥18). Episodes of BSIs were defined according to the strictly described guidelines. Antimicrobial susceptibility testing was performed with the automated system and the disc diffusion method. Extended-spectrum β-lactamases (ESBLs)-producing were detected using the double-disc synergy test. Between 2015 and 2018, 356 episodes of secondary BSIs in 997 patients aged 21-96 years were documented in a prospective study, including 134 (37.6%) ESBL-producing . was the predominant pathogen in internal medicine (37.6%) and surgery units (46.8%); in intensive care units (ICUs), was isolated more frequently (33.3%). were highly resistant to most antimicrobial agents. isolates had a higher level of resistance than , regardless of the unit. The increase in AMR and the widespread distribution of ESBL-producing in Polish hospitals can be related to the lack of or inappropriate antibiotic treatment.
本研究的目的是强调波兰南部医院血流感染分离株中的抗菌药物耐药性。本研究纳入了2015年至2018年住院成年患者(≥18岁)中实验室确诊的继发性血流感染(LC-BSIs)。血流感染发作根据严格描述的指南进行定义。采用自动化系统和纸片扩散法进行抗菌药物敏感性试验。使用双纸片协同试验检测产超广谱β-内酰胺酶(ESBLs)的菌株。在一项前瞻性研究中,记录了2015年至2018年期间997例年龄在21至96岁患者中的356例继发性血流感染发作,其中包括134例(37.6%)产ESBLs的菌株。[具体细菌名称]是内科(37.6%)和外科病房(46.8%)的主要病原体;在重症监护病房(ICU)中,[具体细菌名称]分离频率更高(33.3%)。[具体细菌名称]对大多数抗菌药物高度耐药。无论在哪个病房,[具体细菌名称]分离株的耐药水平都高于[另一具体细菌名称]。波兰医院抗菌药物耐药性的增加以及产ESBLs的[具体细菌名称]的广泛分布可能与抗生素治疗不足或不当有关。